VIRALYSIN

Serial Number 85836157
601

Registration Progress

Application Filed
Jan 30, 2013
Under Examination
Aug 27, 2013
Approved for Publication
Jul 2, 2013
Published for Opposition
Jul 2, 2013
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: VIRALYSIN
Previous Owner: OWEN BIOPHARMA, INC.
Classes: 001

Trademark Image

VIRALYSIN

Basic Information

Serial Number
85836157
Filing Date
January 30, 2013
Published for Opposition
July 2, 2013
Abandonment Date
August 29, 2016
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
601
Status Date
Aug 31, 2016
Classes
001

Rights Holder

OWEN BIOPHARMA, INC.

03
Address
11577 Mercantile Drive
Baton Rouge, LA 70809

Ownership History

TPI Pharma, Inc.

Original Applicant
03
Baton Rouge, LA

OWEN BIOPHARMA, INC.

New Owner Before Publication #1
03
BATON ROUGE, LA

OWEN BIOPHARMA, INC.

Owner at Publication
03
Baton Rouge, LA

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

44 events
Date Code Type Description Documents
Aug 31, 2016 MAB1 O ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT Loading...
Aug 31, 2016 ABN1 O ABANDONMENT - EXPRESS MAILED Loading...
Aug 29, 2016 EXAR I TEAS EXPRESS ABANDONMENT RECEIVED Loading...
Mar 16, 2016 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 15, 2016 EX5G S SOU EXTENSION 5 GRANTED Loading...
Feb 29, 2016 EXT5 S SOU EXTENSION 5 FILED Loading...
Mar 1, 2016 NREV E NOTICE OF REVIVAL - E-MAILED Loading...
Mar 1, 2016 TPEX I SOU EXTENSION RECEIVED WITH TEAS PETITION Loading...
Mar 1, 2016 PETG O PETITION TO REVIVE-GRANTED Loading...
Mar 1, 2016 PROA I TEAS PETITION TO REVIVE RECEIVED Loading...
Aug 18, 2015 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 17, 2015 EX4G S SOU EXTENSION 4 GRANTED Loading...
Aug 13, 2015 EXT4 S SOU EXTENSION 4 FILED Loading...
Aug 13, 2015 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 7, 2015 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 6, 2015 EX3G S SOU EXTENSION 3 GRANTED Loading...
Feb 3, 2015 EXT3 S SOU EXTENSION 3 FILED Loading...
Feb 3, 2015 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 14, 2014 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 13, 2014 EX2G S SOU EXTENSION 2 GRANTED Loading...
Aug 5, 2014 EXT2 S SOU EXTENSION 2 FILED Loading...
Aug 5, 2014 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 4, 2014 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 3, 2014 EX1G S SOU EXTENSION 1 GRANTED Loading...
Feb 5, 2014 EXT1 S SOU EXTENSION 1 FILED Loading...
Mar 2, 2014 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Feb 5, 2014 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 5, 2014 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Feb 5, 2014 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Aug 27, 2013 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 2, 2013 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 2, 2013 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 12, 2013 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 29, 2013 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
May 29, 2013 ALIE A ASSIGNED TO LIE Loading...
May 14, 2013 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 14, 2013 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
May 14, 2013 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
May 14, 2013 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
May 14, 2013 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
May 14, 2013 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 6, 2013 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Feb 5, 2013 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 2, 2013 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
Active chemical ingredients, namely, lipopeptides used in the manufacture of over-the-counter drug and prescriptive pharmaceutical products for the treatment of skin disorders
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
001